Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 6/2012

01-12-2012 | Original Paper

Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica

Authors: Aslam Khan, Saeed R. Khan, Anwar H. Gilani

Published in: Urolithiasis | Issue 6/2012

Login to get access

Abstract

Holarrhena antidysenterica has a traditional use in the treatment of urolithiasis, therefore, its crude extract has been investigated for possible antiurolithic effect. The crude aqueous-methanolic extract of Holarrhena antidysenterica (Ha.Cr) was studied using the in vitro and in vivo methods. In the in vitro experiments, Ha.Cr demonstrated a concentration-dependent (0.25–4 mg/ml) inhibitory effect on the slope of aggregation. It decreased the size of crystals and transformed the calcium oxalate monohydrate (COM) to calcium oxalate dehydrate (COD) crystals, in calcium oxalate metastable solutions. It also showed concentration-dependent antioxidant effect against 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals and lipid peroxidation induced in rat kidney tissue homogenate. Ha.Cr (0.3 mg/ml) reduced (p < 0.05) the cell toxicity and LDH release in renal epithelial cells (MDCK) exposed to oxalate (0.5 mM) and COM (66 μg/cm2) crystals. In male Wistar rats, receiving 0.75 % ethylene glycol (EG) for 21 days along with 1 % ammonium chloride (AC) in drinking water, Ha.Cr treatment (30–100 mg/kg) prevented the toxic changes caused by lithogenic agents; EG and AC, like loss of body weight, polyurea, oxaluria, raised serum urea and creatinine levels and crystal deposition in kidneys compared to their respective controls. These data indicate that Holarrhena antidysenterica possesses antiurolithic activity, possibly mediated through the inhibition of CaOx crystal aggregation, antioxidant and renal epithelial cell protective activities and may provide base for designing future studies to establish its efficacy and safety for clinical use.
Literature
1.
2.
Bashir S, Gilani AH, Siddiqui AA, Pervez S, Khan SR, Sarfaraz NJ, Shah AJ (2010) Berberis vulgaris root bark extract prevents hyperoxaluria induced urolithiasis in rats. Phytother Res 24:1250–1255PubMed
3.
Hussain M, Rizvi SA, Askari H, Sultan G, Lal M, Ali B, Naqvi SA (2009) Management of stone disease: 17 years experience of a stone clinic in a developing country. J Pak Med Assoc 59:843–846PubMed
4.
Srisubat A, Potisat S, Lojanapiwat B, Setthawong V, Laopaiboon M (2009) Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. Cochrane Database Syst Rev CD007044
5.
Qiang W, Ke Z (2004) Water for preventing urinary calculi. Cochrane Database Syst Rev CD004292
6.
Coe FL, Evan AP, Worcester EM, Lingeman JE (2010) Three pathways for human kidney stone formation. Urol Res 38:147–160PubMedCrossRef
7.
Moe OW, Pearle MS, Sakhaee K (2011) Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int 79:385–392PubMedCrossRef
8.
Hess B (2003) Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi. Ther Umsch 60:79–87PubMedCrossRef
9.
Mattle D, Hess B (2005) Preventive treatment of nephrolithiasis with alkali citrate—a critical review. Urol Res 33:73–79PubMedCrossRef
10.
Kmiecik J, Kucharska E, Sulowicz W, Ochmanski W (1997) Etiology and pathogenesis of urolithiasis. Przegl Lek 54:173–179PubMed
11.
Khan A, Bashir S, Khan SR, Gilani AH (2011) Antiurolithic activity of Origanum vulgare is mediated through multiple pathways. BMC Complement Altern Med 11:96PubMedCrossRef
12.
13.
Butterweck V, Khan SR (2009) Herbal medicines in the management of urolithiasis: alternative or complementary? Planta Med 75:1095–1103PubMedCrossRef
14.
Usmanghani K, Saeed A, Alam MT (1997) Indusyunic medicine. University of Karachi Press, Karachi, pp 255–256
15.
Duke JA, Bogenschutz-Godwin MJ, Du celliar J, Duke PK (2002) Handbook of medicinal herbs, 2nd edn. CRC Press, Boca Raton, p 219CrossRef
16.
Kapoor LD (1990) Hand book of ayurvedic medicinal plants. CRC Press, Boca Raton, pp 205–206
17.
Duke JA (1992) Hand book of phytochemical constituents of GRAS herbs and other economic plants. CRC Press, Inc., Boca Raton, pp 292–293
18.
Aqil F, Zahin M, Ahmad I (2008) Antimutagenic activity of methanolic extracts of four ayurvedic medicinal plants. Indian J Exp Biol 46:668–672PubMed
19.
Aqil F, Ahmad I (2007) Antibacterial properties of traditionally used Indian medicinal plants. Methods Find Exp Clin Pharmacol 29:79–92PubMedCrossRef
20.
Atal CK, Sharma ML, Kaul A, Khajuria A (1986) Immunomodulating agents of plant origin. I: preliminary screening. J Ethnopharmacol 18:133–141PubMedCrossRef
21.
Gilani AH, Khan A, Khan AU, Bashir S, Rehman NU, Mandukhail SU (2010) Pharmacological basis for the medicinal use of Holarrhena antidysenterica in gut motility disorders. Pharm Biol 48:1240–1246PubMedCrossRef
22.
Khan A, Bashir S, Gilani AH (2012) An in vivo study on the diuretic activity of Holarrhena antidysenterica. Afr J Pharm Pharmacol 6:454–458
23.
National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC
24.
Williamson EM, Okpako DT, Evans FJ (1996) Selection, preparation, and pharmacological evaluation of plant material. Wiley, Chichester
25.
Bashir S, Gilani AH (2009) Antiurolithic effect of Bergenia ligulata rhizome: an explanation of the underlying mechanisms. J Ethnopharmacol 122:106–116PubMedCrossRef
26.
Ajith TA, Usha S, Nivitha V (2007) Ascorbic acid and [alpha]-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a comparative study. Clin Chim Acta 375:82–86PubMedCrossRef
27.
Kang DG, Yun C, Lee HS (2003) Screening and comparison of antioxidant activity of solvent extracts of herbal medicines used in Korea. J Ethnopharmacol 87:231–236PubMedCrossRef
28.
Atmani F, Slimani Y, Mimouni M, Hacht B (2003) Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int 92:137–140PubMedCrossRef
29.
Bashir S, Gilani AH (2011) Antiurolithic effect of berberine is mediated through multiple pathways. Eur J Pharmacol 651:168–175PubMedCrossRef
30.
Bashir S, Gilani AH (2011) Antiurolithic effect of berberine is mediated through multiple pathways. Eur J Pharmacol 651:168–175
31.
Pizzolato P (1971) Mercurous nitrate as a histochemical reagent for calcium phosphate in bone and pathological calcification and for calcium oxalate. Histochem J 3:463–469PubMedCrossRef
32.
Vanachayangkul P, Chow N, Khan SR, Butterweck V (2010) Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats. Urol Res 33:189–195
33.
Daly JA, Ertingshausen G (1972) Direct method for determining inorganic phosphate in serum with the “CentrifiChem”. Clin Chem 18:263–265PubMed
34.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
35.
Hess B, Meinhardt U, Zipperle L, Giovanoli R, Jaeger P (1995) Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers. Urol Res 23:231–238PubMedCrossRef
36.
37.
Guerra A, Meschi T, Allegri F, Prati B, Nouvenne A, Fiaccadori E, Borghi L (2006) Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load. Urol Res 34:359–364PubMedCrossRef
38.
Wesson JA, Ward MD (2006) Role of crystal surface adhesion in kidney stone disease. Curr Opin Nephrol Hypertens 15:386–393PubMedCrossRef
39.
Sheng X, Ward MD, Wesson JA (2005) Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J Am Soc Nephrol 16:1904–1908PubMedCrossRef
40.
Wang AY (2009) Vascular and other tissue calcification in peritoneal dialysis patients. Perit Dial Int 29(Suppl 2):S9–S14PubMed
41.
42.
Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hori J, Wada N, Hou K (2004) Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology 63:7–11 (discussion 11–12)PubMedCrossRef
43.
Gurocak S, Kupeli B (2006) Consumption of historical and current phytotherapeutic agents for urolithiasis: a critical review. J Urol 176:450–455PubMedCrossRef
44.
Atmani F, Khan SR (2000) Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 85:621–625PubMedCrossRef
45.
Aihara K, Byer KJ, Khan SR (2003) Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int 64:1283–1291PubMedCrossRef
46.
Escobar C, Byer KJ, Khaskheli H, Khan SR (2008) Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones. J Urol 180:379–387PubMedCrossRef
47.
Byer K, Khan SR (2005) Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol 173:640–646PubMedCrossRef
48.
Santhosh Kumar M, Selvam R (2003) Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem 14:306–313PubMedCrossRef
49.
Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3–9PubMed
50.
51.
Zahin M, Aqil F, Ahmad I (2009) The in vitro antioxidant activity and total phenolic content of four Indian medicinal plants International. J pharm pharm Sci 1:88–95
52.
Park HK, Jeong BC, Sung MK, Park MY, Choi EY, Kim BS, Kim HH, Kim JI (2008) Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioflavonoid quercetin. J Urol 179:1620–1626PubMedCrossRef
53.
Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J (2005) Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97:497–501PubMedCrossRef
54.
Michelacci YM, Boim MA, Bergamaschi CT, Rovigatti RM, Schor N (1992) Possible role for chondroitin sulfate in urolithiasis: in vivo studies in an experimental model. Clin Chim Acta 208:1–8PubMedCrossRef
55.
Fan J, Glass MA, Chandhoke PS (1999) Impact of ammonium chloride administration on a rat ethylene glycol urolithiasis model. Scanning Microsc 13:299–306
56.
Tisselius HG (1996) Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven, Philadelphia, pp 33–64
57.
Soundararajan P, Mahesh R, Ramesh T, Begum VH (2006) Effect of Aerva lanata on calcium oxalate urolithiasis in rats. Indian J Exp Biol 44:981–986PubMed
58.
Sangeeta D, Sidhu H, Thind SK, Nath R (1994) Effect of Tribulus terrestris on oxalate metabolism in rats. J Ethnopharmacol 44:61–66PubMedCrossRef
59.
Santhosh Kumar M, Selvam R (2003) Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem 14:306–313PubMedCrossRef
60.
Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS (2001) Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells. Kidney Int 59:637–644PubMedCrossRef
61.
Patel MV, Patel KB, Gupta SN (2010) Effects of Ayurvedic treatment on forty-three patients of ulcerative colitis. Ayu 31:478–481PubMedCrossRef
62.
Pal A, Sharma PP, Mukherjee PK (2009) A Clinical Study of Kutaja (Holarrhena Antidysenterica Wall) on Shonitarsha. Hindu 5(33):33
63.
Paranjpe P, Patki P, Joshi N (2000) Efficacy of an indigenous formulation in patients with bleeding piles: a preliminary clinical study. Fitoterapia 71:41–45PubMedCrossRef
Metadata
Title
Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica
Authors
Aslam Khan
Saeed R. Khan
Anwar H. Gilani
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 6/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-012-0483-1

Other articles of this Issue 6/2012

Urolithiasis 6/2012 Go to the issue

Invited Review

Flexible ureterorenoscopic management of upper tract pathologies

Original Paper

Effect of SWL on renal hemodynamics: could a change in renal artery contraction–relaxation responses be the cause?

Original Paper

Hyperoxaluric rats do not exhibit alterations in renal expression patterns of Slc26a1 (SAT1) mRNA or protein

Letter to the Editor

Knotted ureteral stent: a rare complication of ureteral stent usage

Original Paper

Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli

Original Paper

Osteopenia/osteoporosis in patients with calcium nephrolithiasis